Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma
Cancer Medicine · 2024
DOI: 10.1002/cam4.7195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Han Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Acquired Immunodeficiency Syndrome, Epstein-Barr Virus Infections, Lymphoma, Non-Hodgkin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GuangDong Basic and Applied Basic Research Foundation, Municipal and University (Hospital) joint funding project of Guangzhou Municipal Science and Technology Bureau, Clinical Research Program of Nanfang Hospital, Southern Medical University.
Abstract (Originalsprache)
Objective
Immune tolerance and evasion play a critical role in virus‐driven malignancies. However, the phenotype and clinical significance of programmed cell death 1 (PD‐1) and its ligands, PD‐L1 and PD‐L2, in aggressive acquired immunodeficiency syndrome (AIDS)‐related non‐Hodgkin lymphoma (AR‐NHL) remain poorly understood, particularly in the Epstein–Barr virus (EBV)‐positive subset.
Methods
We used in situ hybridization with EBV‐encoded RNA (EBER) to assess the EBV status. We performed immunohistochemistry and flow cytometry analysis to evaluate components of the PD‐1/PD‐L1/L2 pathway in a multi‐institutional cohort of 58 patients with AR‐NHL and compared EBV‐positive and EBV‐negative cases.
Results
The prevalence of EBV + in AR‐NHL was 56.9% and was associated with a marked increase in the expression of PD‐1/PD‐L1/PD‐L2 in malignant cells. Patients with AR‐NHLs who tested positive for both EBER and PD‐1 exhibited lower survival rates compared to those negative for these markers (47.4% vs. 93.8%, p = 0.004). Similarly, patients positive for both EBER and PD‐L1 also demonstrated poorer survival (56.5% vs. 93.8%, p = 0.043). Importantly, PD‐1 tissue‐expression demonstrated independent prognostic significance for overall survival in multivariate analysis and was correlated to elevated levels of LDH ( r = 0.313, p = 0.031), increased PD‐1 + Tregs ( p = 0.006), and robust expression of EBER ( r = 0.541, p < 0.001) and PD‐L1 ( r = 0.354, p = 0.014) expression.
Conclusions
These data emphasize the importance of PD‐1‐mediated immune evasion in the complex landscape of immune oncology in AR‐NHL co‐infected with EBV, and contribute to the diagnostic classification and possible definition of immunotherapeutic strategies for this unique subgroup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Infectious Diseases Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Pathology department, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
- Guangxi AIDS Clinical Treatment Center, the Fourth People's Hospital of Nanning, Nanning, China.
ORCID-Profile: Han Zhao, Juanjuan Chen
Förderung
- GuangDong Basic and Applied Basic Research Foundation
- Municipal and University (Hospital) joint funding project of Guangzhou Municipal Science and Technology Bureau
- Clinical Research Program of Nanfang Hospital, Southern Medical University
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhao, H., Cai, S., Xiao, Y., Xia, M., Chen, H., Xie, Z., Tang, X., He, H., Peng, J., & Chen, J. (2024). Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma. Cancer Medicine. https://doi.org/10.1002/cam4.7195
Vancouver
Zhao H, Cai S, Xiao Y, Xia M, Chen H, Xie Z, et al. Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma. Cancer Medicine. 2024. doi:10.1002/cam4.7195
BibTeX
@article{Zhao2024,
author = {Zhao, Han and Cai, Shaohang and Xiao, Yanhua and Xia, Muye and Chen, Hongjie and Xie, Zhiman and Tang, Xiaoping and He, Haolan and Peng, Jie and Chen, Juanjuan},
title = {Expression and prognostic significance of the PD ‐1/ PD‐L1 pathway in AIDS ‐related non‐Hodgkin lymphoma},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7195}
}
EUVIMED